Prevalence of Joint Symptoms in Postmenopausal Women Taking Aromatase Inhibitors for Early-Stage Breast Cancer Twenty-five patients (median age, 70 years) were enrolled; 12 were untreated and 13 had ...
A 10-day low-dose Dacogen regimen showed a 33% response rate in myelofibrosis patients, with a median response duration of seven months. High prognostic scores, elevated fetal hemoglobin, and reduced ...
Otsuka has acquired rights from Eisai Inc. to develop and sell in the US, Canada and Japan the DNA methylation inhibitor Dacogen ®. In addition, Otsuka has acquired licensing rights worldwide, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback